Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05117918 · ClinicalTrials.gov registry record · NA
Overactive Bladder Telemedicine Non-inferiority Trial
A NA study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 177
- Enrollment target
NCT05117918: Completed NA study, sponsored by University of California, Los Angeles.
NCT05117918 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 177 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05117918, a NA study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 177 participants
- Enrollment target
Study Summary
In this study, the investigators aim to validate the telemedicine paradigm as a feasible alternative to traditional in-person clinic visits for the management of overactive bladder (OAB).
Primary Outcome
Treatment Satisfaction Visual Analogue Scale (TS-VAS), scale scored from 0 - 100 with 100 indicating highest satisfaction
Interventions
- OTHER Telemedicine
- OTHER SUFU Clinical Care Pathway for Overactive Bladder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 177 participants |
| Start Date | 2021-07-01 |
| Est. Completion | 2023-08-31 |
| Phase | NA |
What the finished NCT05117918 record still lists
NCT05117918 is an interventional study that assigns participants to a tested intervention. The registered 177 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower).
The record links to 0 conditions, and to 2 interventions - of which Telemedicine is the first listed.
NCT05117918 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05117918 about?
NCT05117918 is a clinical study titled "Overactive Bladder Telemedicine Non-inferiority Trial". In this study, the investigators aim to validate the telemedicine paradigm as a feasible alternative to traditional in-person clinic visits for the management of overactive bladder (OAB).
What is the current status of trial NCT05117918?
This trial is currently completed. It is a NA study. The enrollment target is 177 participants. The study started on 2021-07-01. Estimated completion is 2023-08-31.
What interventions are being tested in trial NCT05117918?
The interventions under investigation include: Telemedicine (OTHER), SUFU Clinical Care Pathway for Overactive Bladder (OTHER).
Who is sponsoring clinical trial NCT05117918?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05117918's enrollment target sits among peer trials
177 604th of 2000 higher than 1,396 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05491551 · 177 participants · NA
Alcohol-ROC-Training
- NCT06108050 · 177 participants · Phase 1
JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid Tumors
- NCT06575712 · 177 participants · NA
Coping Skills Training for Symptom Management and Daily Steps (Step Up)
- NCT06674980 · 177 participants · NA
Clinical Trial Assessing Human Placental Membrane Products and Standard of Care Versus Standard of Care in Nonhealing DFUs and VLUs
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI